Person who experienced the adverse event (patient)
Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
127832551 | 12783255 | 1 | I | 20160926 | 0 | 20160927 | 20160927 | DIR | US-FDA-351615 | FDA-CTU | 30.00 | YR | M | N | 128.25000 | KG | 20160927 | Y | US | US |
Drug(s) used by person
Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
127832551 | 12783255 | 1 | PS | VYVANSE | LISDEXAMFETAMINE DIMESYLATE | 1 | Oral | Y | Y | 0 | 1 | G | |||||||
127832551 | 12783255 | 2 | C | FISH OIL | FISH OIL | 1 | 0 | ||||||||||||
127832551 | 12783255 | 4 | C | MULTI | 2 | 0 | |||||||||||||
127832551 | 12783255 | 6 | C | VITAMIN D3 | CHOLECALCIFEROL | 1 | 0 | ||||||||||||
127832551 | 12783255 | 8 | C | MAGNESIUM | MAGNESIUM | 1 | 0 |
Indications of drugs used
Event ID | CASEID | INDI DRUG SEQ | INDI PT |
---|---|---|---|
127832551 | 12783255 | 1 | Attention deficit/hyperactivity disorder |
Outcome of event
no results found |
Reactions reported
Event ID | CASEID | DRUG REC ACT | PT |
---|---|---|---|
127832551 | 12783255 | Amnesia | |
127832551 | 12783255 | Aphasia | |
127832551 | 12783255 | Confusional state | |
127832551 | 12783255 | Feeling abnormal | |
127832551 | 12783255 | Incoherent |
Reporting Sources (this data is often not reported and may therefore be missing here)
no results found |
Therapies reported
Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
---|---|---|---|---|---|---|
127832551 | 12783255 | 1 | 20160919 | 20160926 | 0 |